SWP
VRTX icon

Strategic Wealth Partners’s Vertex Pharmaceuticals VRTX Stock Holding History

Strategic Wealth Partners’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.26M Buy
5,058
+498
+11% +$232K 0.16% 102
2025
Q4 		$2.07M Sell
4,560
-483
-10% -$208K 0.14% 111
2025
Q3 		$1.98M Buy
5,043
+23
+0.5% +$9.61K 0.15% 103
2025
Q2 		$2.23M Buy
+5,020
New +$2.31M 0.18% 97
2024
Q4 		$1.7M Buy
3,680
+479
+15% +$222K 0.14% 111
2024
Q3 		$1.49M Buy
3,201
+294
+10% +$141K 0.14% 117
2024
Q2 		$1.36M Buy
2,907
+54
+2% +$23.4K 0.14% 116
2024
Q1 		$1.19M Buy
2,853
+460
+19% +$194K 0.13% 119
2023
Q4 		$974K Buy
2,393
+294
+14% +$109K 0.12% 129
2023
Q3 		$730K Sell
2,099
-45
-2% -$15.7K 0.1% 172
2023
Q2 		$754K Buy
2,144
+12
+0.6% +$4.04K 0.1% 171
2023
Q1 		$672K Buy
2,132
+174
+9% +$52.2K 0.1% 152
2022
Q4 		$565K Buy
+1,958
New +$597K 0.11% 159
2021
Q2 		– Sell
-2,514
Closed -$540K – 261
2021
Q1 		$540K Buy
2,514
+1,487
+145% +$327K 0.22% 115
2020
Q4 		$243K Buy
+1,027
New +$236K 0.1% 160
2018
Q2 		– Sell
-113
Closed -$18K – 837
2018
Q1 		$18K Hold
113
– – 0.01% 387
2017
Q4 		$17K Buy
+113
New +$16.7K 0.01% 381

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Strategic Wealth Partners's VRTX Position: Q1 2026 in Review

Strategic Wealth Partners increased its Vertex Pharmaceuticals (VRTX) stake by 11% in Q1 2026, buying an estimated $232K and bringing the position to 5,058 shares worth $2.26M. The position accounts for 0.16% of the portfolio, ranked #102.

Strategic Wealth Partners first reported a position in VRTX in Q4 2017 and has held it in 17 quarters since. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • Strategic Wealth Partners held 5,058 shares of Vertex Pharmaceuticals worth $2.26M as of Q1 2026.
  • Strategic Wealth Partners bought 498 Vertex Pharmaceuticals shares in Q1 2026, an estimated $232K.
  • Vertex Pharmaceuticals made up 0.16% of Strategic Wealth Partners's portfolio in Q1 2026, its #102 holding.
  • Strategic Wealth Partners first reported a position in Vertex Pharmaceuticals in Q4 2017 and has held it in 17 quarters since.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Strategic Wealth Partners's 13F filing for Q1 2026, filed 12 May 2026.